Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ITPA - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC4A11 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
DDRGK1 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
LZTS3 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
FASTKD5 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
UBOX5 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
C20orf194 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
GEO DataSets Gene Chromosome neighbors Homologene neighbors
AVP - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
OXT - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
MRPS26 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
GNRH2 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
ATRN - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
GFRA4 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
ADAM33 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on